David Roblin
Before joining the European biotech, Roblin held leadership roles in Pfizer and Bayer across a wide range of therapy areas in research, development and commercial roles.
He was most recently senior VP and head of research for European research and development (R&D) at Pfizer.
Eliot Forster, CEO of Creabilis, said: "It is reflection of Creabilis' potential that we have been able to attract a Chief Medical Officer of David's caliber and reputation.
“He has vast experience not only in clinical development, but across the broader drug development pathway and pharmaceutical industry as a whole.”